1. Home
  2. TECH vs NIO Comparison

TECH vs NIO Comparison

Compare TECH & NIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$65.12

Market Cap

9.2B

Sector

Health Care

ML Signal

HOLD

Logo NIO Inc. American depositary shares each  representing one ordinary share

NIO

NIO Inc. American depositary shares each representing one ordinary share

HOLD

Current Price

$4.79

Market Cap

12.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECH
NIO
Founded
1976
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
12.8B
IPO Year
1989
2018

Fundamental Metrics

Financial Performance
Metric
TECH
NIO
Price
$65.12
$4.79
Analyst Decision
Buy
Buy
Analyst Count
14
9
Target Price
$70.46
$6.73
AVG Volume (30 Days)
1.6M
40.5M
Earning Date
02-04-2026
11-25-2025
Dividend Yield
0.49%
N/A
EPS Growth
N/A
N/A
EPS
0.49
N/A
Revenue
$1,216,732,000.00
$10,189,444,895.00
Revenue This Year
$2.33
$33.27
Revenue Next Year
$7.05
$50.24
P/E Ratio
$134.12
N/A
Revenue Growth
3.85
14.90
52 Week Low
$46.01
$3.02
52 Week High
$79.28
$8.02

Technical Indicators

Market Signals
Indicator
TECH
NIO
Relative Strength Index (RSI) 68.64 38.91
Support Level $58.40 $4.74
Resistance Level $66.48 $5.04
Average True Range (ATR) 1.57 0.19
MACD 0.78 0.02
Stochastic Oscillator 86.10 6.13

Price Performance

Historical Comparison
TECH
NIO

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About NIO NIO Inc. American depositary shares each representing one ordinary share

Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.

Share on Social Networks: